Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
Five RECOVER study sites across the Pacific Northwest teamed up to form a consortium. Consortium members learn from other RECOVER researchers’ findings and share knowledge with the community.
On November 21, NIAID and FNIH launched its first in a series of online webinars highlighting recent progress in the new Researching COVID to Enhance Recovery - Treating Long COVID (RECOVER-TLC) program.
Recent findings from across RECOVER’s five research areas could improve our ability to identify people with Long COVID, understand the underlying causes of their symptoms, and provide them with care and treatment.
By reviewing patient medical records from as early as March 2020, the findings from these studies provide insights into potential risks associated with developing Long COVID.
NIH leaders will discuss the current status of RECOVER-TLC, share information about potential Long COVID treatments to be tested in RECOVER-TLC clinical trials, and answer questions from the public.
RECOVER-TLC invites the Long COVID community to submit ideas for potential Long COVID treatments and biomarkers, volunteers for working groups, and provide feedback on the next phase of Long COVID clinical trials.
During the October 8th RECOVER Research Review (R3) Seminar, researchers described how RECOVER and the All of Us Research Program collaborate to advance our understanding of Long COVID. These different National Institutes of Health (NIH) initiatives are sharing health data and developing innovative tools to gain important insights from that data.
A research team at RECOVER’s South Dakota study site prioritizes diversity and accessibility in clinical trial enrollment.
RECOVER researchers at the University of New Mexico study site have built connections between RECOVER studies and the university’s Long COVID clinic to ensure patients have access to resources and care.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.